• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浅析微生理系统在药物转运体研究中的应用

Perspective on the Application of Microphysiological Systems to Drug Transporter Studies.

机构信息

Mechanistic Safety and ADME Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.

Mechanistic Safety and ADME Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom

出版信息

Drug Metab Dispos. 2018 Nov;46(11):1647-1657. doi: 10.1124/dmd.118.082750. Epub 2018 Aug 22.

DOI:10.1124/dmd.118.082750
PMID:30135246
Abstract

Transmembrane flux of a drug within a tissue or organ frequently involves a complex system of transporters from multiple families that have redundant and overlapping specificities. Current in vitro systems poorly represent physiology, with reduced expression and activity of drug transporter proteins; therefore, novel models that recapitulate the complexity and interplay among various transporters are needed. The development of microphysiological systems that bring simulated physiologic conditions to in vitro cell culture models has enormous potential to better reproduce the morphology and transport activity across several organ models, especially in tissues such as the liver, kidney, intestine, or the blood-brain barrier, in which drug transporters play a key role. The prospect of improving the in vitro function of organ models highly prolific in drug transporters holds the promise of implementing novel tools to study these mechanisms with far more representative biology than before. In this short review, we exemplify recent developments in the characterization of perfused microphysiological systems involving the activity of drug transporters. Furthermore, we analyze the challenges and opportunities for the implementation of such systems in the study of transporter-mediated drug disposition and the generation of clinically relevant physiology-based in silico models incorporating relevant drug transport activity.

摘要

药物在组织或器官内的跨膜通量通常涉及来自多个家族的多种转运体的复杂系统,这些转运体具有冗余和重叠的特异性。当前的体外系统不能很好地反映生理学,药物转运蛋白的表达和活性降低;因此,需要新型模型来再现各种转运体之间的复杂性和相互作用。将模拟生理条件的微生理系统应用于体外细胞培养模型的发展具有巨大的潜力,可以更好地复制多个器官模型的形态和转运活性,特别是在肝脏、肾脏、肠道或血脑屏障等组织中,药物转运体在其中发挥着关键作用。改善富含药物转运体的器官模型的体外功能有望实现新的工具,以前所未有的更具代表性的生物学来研究这些机制。在这篇简短的综述中,我们举例说明了最近在涉及药物转运体活性的灌注微生理系统的表征方面的进展。此外,我们分析了在研究转运体介导的药物处置和生成包含相关药物转运活性的基于临床相关生理学的计算模型时实施此类系统的挑战和机遇。

相似文献

1
Perspective on the Application of Microphysiological Systems to Drug Transporter Studies.浅析微生理系统在药物转运体研究中的应用
Drug Metab Dispos. 2018 Nov;46(11):1647-1657. doi: 10.1124/dmd.118.082750. Epub 2018 Aug 22.
2
Drug transporters in pharmacokinetics.药代动力学中的药物转运体
Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):465-75. doi: 10.1007/s00210-006-0042-9. Epub 2006 Mar 11.
3
Protein-protein interactions of drug uptake transporters that are important for liver and kidney.药物摄取转运体的蛋白-蛋白相互作用对肝脏和肾脏很重要。
Biochem Pharmacol. 2019 Oct;168:384-391. doi: 10.1016/j.bcp.2019.07.026. Epub 2019 Aug 2.
4
Liver transporters in hepatic drug disposition: an update.肝脏药物处置中的肝转运体:最新进展
Curr Drug Metab. 2009 Jun;10(5):482-98. doi: 10.2174/138920009788898037.
5
Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.药物外排转运体与药代动力学预测。
Drug Metab Dispos. 2018 May;46(5):561-566. doi: 10.1124/dmd.118.081356.
6
Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.载体介导的药物摄取和外排:药物不良反应的重要决定因素。
Clin Pharmacol Ther. 2011 Jun;89(6):798-805. doi: 10.1038/clpt.2010.354. Epub 2011 Apr 6.
7
Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.药物研发中治疗性分子的转运体介导的组织靶向作用。
Bioorg Med Chem Lett. 2015 Mar 1;25(5):993-7. doi: 10.1016/j.bmcl.2015.01.016. Epub 2015 Jan 24.
8
Transporter-mediated drug-drug interactions: advancement in models, analytical tools, and regulatory perspective.载体介导的药物相互作用:模型、分析工具和监管视角的进展。
Drug Metab Rev. 2021 Aug;53(3):285-320. doi: 10.1080/03602532.2021.1928687. Epub 2021 Jun 2.
9
Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function.芯片上的肝脏和肾脏:用于理解转运体功能的微生理模型
Clin Pharmacol Ther. 2016 Nov;100(5):464-478. doi: 10.1002/cpt.436. Epub 2016 Aug 27.
10
Intestinal drug transporters: an overview.肠道药物转运体:概述。
Adv Drug Deliv Rev. 2013 Oct;65(10):1340-56. doi: 10.1016/j.addr.2012.09.042. Epub 2012 Oct 4.

引用本文的文献

1
Addressing the ADME Challenges of Compound Loss in a PDMS-Based Gut-on-Chip Microphysiological System.解决基于聚二甲基硅氧烷(PDMS)的芯片肠道微生理系统中化合物损失的吸收、分布、代谢和排泄(ADME)挑战。
Pharmaceutics. 2024 Feb 20;16(3):296. doi: 10.3390/pharmaceutics16030296.
2
New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.新型和新兴溶质载体和三磷酸腺苷结合盒转运蛋白在药物发现和开发中的研究:国际转运蛋白联合会的展望。
Clin Pharmacol Ther. 2022 Sep;112(3):540-561. doi: 10.1002/cpt.2627. Epub 2022 May 20.
3
Microphysiological systems in absorption, distribution, metabolism, and elimination sciences.
在吸收、分布、代谢和消除科学中的微观生理系统。
Clin Transl Sci. 2022 Jan;15(1):9-42. doi: 10.1111/cts.13132. Epub 2021 Aug 26.
4
3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.3D 细胞培养模型:药物药代动力学、安全性评估和监管考虑。
Clin Transl Sci. 2021 Sep;14(5):1659-1680. doi: 10.1111/cts.13066. Epub 2021 Jun 16.